Skip to content

21st Century Oncology Holdings, Inc.

company.status.inactive

CIK 1503518fmd_0QRDP7M0JGPV2PGY679M10D1PMServices · Services-Offices & Clinics of Doctors of MedicineTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2016, 27 periods

Latest annual · FY2015

Millions
Gross profit
308
Net income
(135)
Free cash flow
(32)

Latest quarter · Q3 FY2016

Millions
Gross profit
66
Net income
(80)
Free cash flow
(11)
Open Financials

Key stats

Open Analysis

Compound annual growth

Net income, 5 yearsFY2010 to FY2015
n/m

21st Century Oncology Holdings, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2015FY2014ChangeSource
Gross profit$308.4 million$295.8 million+4.3%10-K 2016-08-23 · proof
Net income-$134.8 million-$357.3 million10-K 2016-08-23 · proof
Cash from operating activities$8.4 million-$14.8 million10-K 2016-08-23 · proof
Free cash flow-$32.5 million-$71.4 million10-K 2016-08-23 · proof
Total assets$1.1 billion$1.2 billion-4.3%10-Q 2016-09-20 · proof
Total liabilities$1.4 billion$1.3 billion+9.1%10-Q 2016-09-20 · proof
Cash and cash equivalents$65.2 million$99.1 million-34.2%10-K 2016-08-23 · proof
Total debt$1.1 billion$967.1 million+11%10-Q 2016-09-20 · proof
What was 21st Century Oncology Holdings, Inc.'s gross profit in fiscal 2015?
21st Century Oncology Holdings, Inc. reported gross profit of $308.4 million for fiscal 2015 (the year ended Dec 31, 2015), against $295.8 million the year before (+4.3%). Source: the 10-K filed with the SEC on Aug 23, 2016. SEC
What was 21st Century Oncology Holdings, Inc.'s net income in fiscal 2015?
21st Century Oncology Holdings, Inc. reported net income of -$134.8 million for fiscal 2015 (the year ended Dec 31, 2015), against -$357.3 million the year before. Source: the 10-K filed with the SEC on Aug 23, 2016. SEC
What was 21st Century Oncology Holdings, Inc.'s cash from operating activities in fiscal 2015?
21st Century Oncology Holdings, Inc. reported cash from operating activities of $8.4 million for fiscal 2015 (the year ended Dec 31, 2015), against -$14.8 million the year before. Source: the 10-K filed with the SEC on Aug 23, 2016. SEC
What was 21st Century Oncology Holdings, Inc.'s free cash flow in fiscal 2015?
21st Century Oncology Holdings, Inc. reported free cash flow of -$32.5 million for fiscal 2015 (the year ended Dec 31, 2015), against -$71.4 million the year before. Source: the 10-K filed with the SEC on Aug 23, 2016. SEC
What are 21st Century Oncology Holdings, Inc.'s total assets?
As of Dec 31, 2015, 21st Century Oncology Holdings, Inc. reported total assets of $1.1 billion, against $1.2 billion a year earlier (-4.3%). Source: the 10-Q filed with the SEC on Sep 20, 2016 (restated). SEC
What are 21st Century Oncology Holdings, Inc.'s total liabilities?
As of Dec 31, 2015, 21st Century Oncology Holdings, Inc. reported total liabilities of $1.4 billion, against $1.3 billion a year earlier (+9.1%). Source: the 10-Q filed with the SEC on Sep 20, 2016 (restated). SEC
What are 21st Century Oncology Holdings, Inc.'s cash and cash equivalents?
As of Dec 31, 2015, 21st Century Oncology Holdings, Inc. reported cash and cash equivalents of $65.2 million, against $99.1 million a year earlier (-34.2%). Source: the 10-K filed with the SEC on Aug 23, 2016. SEC
What is 21st Century Oncology Holdings, Inc.'s total debt?
As of Dec 31, 2015, 21st Century Oncology Holdings, Inc. reported total debt of $1.1 billion, against $967.1 million a year earlier (+11%). Source: the 10-Q filed with the SEC on Sep 20, 2016 (restated). SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1503518&period_type=annual&limit=5"

Information only, not investment advice.